This extract is from a medical magazine called Vaccine. It appeared in Vol 9, August 1991.
I have offered this piece because it was published after the Gulf conflict and indicates that the use of an adjuvant are still in the experimental stages.
I have only extracted what I consider to be the relevant
parts, however, the full article is available on request.
Page 536 para 3. line 13
The addition of totally non-specific cellular entities such as killed Corynebacterium ovis, Bordetella pertussis or Freund's complete adjuvant to either the human vaccines or purified PA enhanced their positive effects.
Page 537 para (table 3) line 15
This vaccine is essentially ready for clinical trials although a source of funding to cover this complex process has not been identified yet.
Top of Page | Current Section Index |
---|